According to this latest study, the 2021 growth of Injectable Sumatriptan will have significant change from previous year. By the most conservative estimates of global Injectable Sumatriptan market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Injectable Sumatriptan market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Injectable Sumatriptan market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
4mg
6mg
Others
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Hospitals
Clinics
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
GlaxoSmithKline
Pfizer
Teva
Sun Pharma
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Injectable Sumatriptan Consumption 2016-2026
2.1.2 Injectable Sumatriptan Consumption CAGR by Region
2.2 Injectable Sumatriptan Segment by Type
2.2.1 4mg
2.2.2 6mg
2.2.3 Others
2.3 Injectable Sumatriptan Sales by Type
2.3.1 Global Injectable Sumatriptan Sales Market Share by Type (2016-2021)
2.3.2 Global Injectable Sumatriptan Revenue and Market Share by Type (2016-2021)
2.3.3 Global Injectable Sumatriptan Sale Price by Type (2016-2021)
2.4 Injectable Sumatriptan Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Injectable Sumatriptan Sales by Application
2.5.1 Global Injectable Sumatriptan Sale Market Share by Application (2016-2021)
2.5.2 Global Injectable Sumatriptan Revenue and Market Share by Application (2016-2021)
2.5.3 Global Injectable Sumatriptan Sale Price by Application (2016-2021)
3 Global Injectable Sumatriptan by Company
3.1 Global Injectable Sumatriptan Sales Market Share by Company
3.1.1 Global Injectable Sumatriptan Sales by Company (2019-2021)
3.1.2 Global Injectable Sumatriptan Sales Market Share by Company (2019-2021)
3.2 Global Injectable Sumatriptan Revenue Market Share by Company
3.2.1 Global Injectable Sumatriptan Revenue by Company (2019-2021)
3.2.2 Global Injectable Sumatriptan Revenue Market Share by Company (2019-2021)
3.3 Global Injectable Sumatriptan Sale Price by Company
3.4 Global Manufacturers Injectable Sumatriptan Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Injectable Sumatriptan Product Location Distribution
3.4.2 Players Injectable Sumatriptan Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Injectable Sumatriptan by Region
4.1 Global Injectable Sumatriptan by Region
4.1.1 Global Injectable Sumatriptan Sales by Region
4.1.2 Global Injectable Sumatriptan Revenue by Region
4.2 Americas Injectable Sumatriptan Sales Growth
4.3 APAC Injectable Sumatriptan Sales Growth
4.4 Europe Injectable Sumatriptan Sales Growth
4.5 Middle East & Africa Injectable Sumatriptan Sales Growth
5 Americas
5.1 Americas Injectable Sumatriptan Sales by Country
5.1.1 Americas Injectable Sumatriptan Sales by Country (2016-2021)
5.1.2 Americas Injectable Sumatriptan Revenue by Country (2016-2021)
5.2 Americas Injectable Sumatriptan Sales by Type
5.3 Americas Injectable Sumatriptan Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Injectable Sumatriptan Sales by Region
6.1.1 APAC Injectable Sumatriptan Sales by Region (2016-2021)
6.1.2 APAC Injectable Sumatriptan Revenue by Region (2016-2021)
6.2 APAC Injectable Sumatriptan Sales by Type
6.3 APAC Injectable Sumatriptan Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Injectable Sumatriptan by Country
7.1.1 Europe Injectable Sumatriptan Sales by Country (2016-2021)
7.1.2 Europe Injectable Sumatriptan Revenue by Country (2016-2021)
7.2 Europe Injectable Sumatriptan Sales by Type
7.3 Europe Injectable Sumatriptan Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Injectable Sumatriptan by Country
8.1.1 Middle East & Africa Injectable Sumatriptan Sales by Country (2016-2021)
8.1.2 Middle East & Africa Injectable Sumatriptan Revenue by Country (2016-2021)
8.2 Middle East & Africa Injectable Sumatriptan Sales by Type
8.3 Middle East & Africa Injectable Sumatriptan Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Injectable Sumatriptan Distributors
10.3 Injectable Sumatriptan Customer
11 Global Injectable Sumatriptan Market Forecast
11.1 Global Injectable Sumatriptan Forecast by Region
11.1.1 Global Injectable Sumatriptan Forecast by Regions (2021-2026)
11.2.2 Global Injectable Sumatriptan Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Injectable Sumatriptan Forecast by Type
11.7 Global Injectable Sumatriptan Forecast by Application
12 Key Players Analysis
12.1 GlaxoSmithKline
12.1.1 GlaxoSmithKline Company Information
12.1.2 GlaxoSmithKline Injectable Sumatriptan Product Offered
12.1.3 GlaxoSmithKline Injectable Sumatriptan Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 GlaxoSmithKline Main Business Overview
12.1.5 GlaxoSmithKline Latest Developments
12.2 Pfizer
12.2.1 Pfizer Company Information
12.2.2 Pfizer Injectable Sumatriptan Product Offered
12.2.3 Pfizer Injectable Sumatriptan Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Pfizer Main Business Overview
12.2.5 Pfizer Latest Developments
12.3 Teva
12.3.1 Teva Company Information
12.3.2 Teva Injectable Sumatriptan Product Offered
12.3.3 Teva Injectable Sumatriptan Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Teva Main Business Overview
12.3.5 Teva Latest Developments
12.4 Sun Pharma
12.4.1 Sun Pharma Company Information
12.4.2 Sun Pharma Injectable Sumatriptan Product Offered
12.4.3 Sun Pharma Injectable Sumatriptan Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Sun Pharma Main Business Overview
12.4.5 Sun Pharma Latest Developments
...
13 Research Findings and Conclusion
List of Tables
Table 1. Injectable Sumatriptan Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of 4mg
Table 3. Major Players of 6mg
Table 4. Major Players of Others
Table 5. Global Injectable Sumatriptan Sales by Type (2016-2021) & (K Units)
Table 6. Global Injectable Sumatriptan Sales Market Share by Type (2016-2021)
Table 7. Global Injectable Sumatriptan Revenue by Type (2016-2021) & ($ million)
Table 8. Global Injectable Sumatriptan Revenue Market Share by Type (2016-2021)
Table 9. Global Injectable Sumatriptan Sale Price by Type (2016-2021)
Table 10. Global Injectable Sumatriptan Sales by Application (2016-2021) & (K Units)
Table 11. Global Injectable Sumatriptan Sales Market Share by Application (2016-2021)
Table 12. Global Injectable Sumatriptan Value by Application (2016-2021)
Table 13. Global Injectable Sumatriptan Revenue Market Share by Application (2016-2021)
Table 14. Global Injectable Sumatriptan Sale Price by Application (2016-2021)
Table 15. Global Injectable Sumatriptan Sales by Company (2019-2021) & (K Units)
Table 16. Global Injectable Sumatriptan Sales Market Share by Company (2019-2021)
Table 17. Global Injectable Sumatriptan Revenue by Company (2019-2021) ($ Millions)
Table 18. Global Injectable Sumatriptan Revenue Market Share by Company (2019-2021)
Table 19. Global Injectable Sumatriptan Sale Price by Company (2019-2021)
Table 20. Key Manufacturers Injectable Sumatriptan Producing Area Distribution and Sales Area
Table 21. Players Injectable Sumatriptan Products Offered
Table 22. Injectable Sumatriptan Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Injectable Sumatriptan Sales by Region (2016-2021) (K Units)
Table 26. Global Injectable Sumatriptan Sales Market Share by Region (2016-2021)
Table 27. Global Injectable Sumatriptan Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global Injectable Sumatriptan Revenue Market Share by Region (2016-2021)
Table 29. Americas Injectable Sumatriptan Sales by Country (2016-2021) & (K Units)
Table 30. Americas Injectable Sumatriptan Sales Market Share by Country (2016-2021)
Table 31. Americas Injectable Sumatriptan Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas Injectable Sumatriptan Revenue Market Share by Country (2016-2021)
Table 33. Americas Injectable Sumatriptan Sales by Type (2016-2021) & (K Units)
Table 34. Americas Injectable Sumatriptan Sales Market Share by Type (2016-2021)
Table 35. Americas Injectable Sumatriptan Sales by Application (2016-2021) & (K Units)
Table 36. Americas Injectable Sumatriptan Sales Market Share by Application (2016-2021)
Table 37. APAC Injectable Sumatriptan Sales by Region (2016-2021) & (K Units)
Table 38. APAC Injectable Sumatriptan Sales Market Share by Region (2016-2021)
Table 39. APAC Injectable Sumatriptan Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC Injectable Sumatriptan Revenue Market Share by Region (2016-2021)
Table 41. APAC Injectable Sumatriptan Sales by Type (2016-2021) & (K Units)
Table 42. APAC Injectable Sumatriptan Sales Market Share by Type (2016-2021)
Table 43. APAC Injectable Sumatriptan Sales by Application (2016-2021) & (K Units)
Table 44. APAC Injectable Sumatriptan Sales Market Share by Application (2016-2021)
Table 45. Europe Injectable Sumatriptan Sales by Country (2016-2021) & (K Units)
Table 46. Europe Injectable Sumatriptan Sales Market Share by Country (2016-2021)
Table 47. Europe Injectable Sumatriptan Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe Injectable Sumatriptan Revenue Market Share by Country (2016-2021)
Table 49. Europe Injectable Sumatriptan Sales by Type (2016-2021) & (K Units)
Table 50. Europe Injectable Sumatriptan Sales Market Share by Type (2016-2021)
Table 51. Europe Injectable Sumatriptan Sales by Application (2016-2021) & (K Units)
Table 52. Europe Injectable Sumatriptan Sales Market Share by Application (2016-2021)
Table 53. Middle East & Africa Injectable Sumatriptan Sales by Country (2016-2021) & (K Units)
Table 54. Middle East & Africa Injectable Sumatriptan Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa Injectable Sumatriptan Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa Injectable Sumatriptan Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa Injectable Sumatriptan Sales by Type (2016-2021) & (K Units)
Table 58. Middle East & Africa Injectable Sumatriptan Sales Market Share by Type (2016-2021)
Table 59. Middle East & Africa Injectable Sumatriptan Sales by Application (2016-2021) & (K Units)
Table 60. Middle East & Africa Injectable Sumatriptan Sales Market Share by Application (2016-2021)
Table 61. Key and Potential Regions of Injectable Sumatriptan
Table 62. Key Application and Potential Industries of Injectable Sumatriptan
Table 63. Key Challenges of Injectable Sumatriptan
Table 64. Key Trends of Injectable Sumatriptan
Table 65. Injectable Sumatriptan Distributors List
Table 66. Injectable Sumatriptan Customer List
Table 67. Global Injectable Sumatriptan Sales Forecast by Region (2021-2026) & (K Units)
Table 68. Global Injectable Sumatriptan Consumption Market Forecast by Region
Table 69. Global Injectable Sumatriptan Revenue Forecast by Region (2021-2026) & ($ millions)
Table 70. Global Injectable Sumatriptan Revenue Market Share Forecast by Region (2021-2026)
Table 71. Americas Injectable Sumatriptan Sales Forecast by Country (2021-2026) & (K Units)
Table 72. Americas Injectable Sumatriptan Revenue Forecast by Country (2021-2026) & ($ millions)
Table 73. APAC Injectable Sumatriptan Sales Forecast by Region (2021-2026) & (K Units)
Table 74. APAC Injectable Sumatriptan Revenue Forecast by Region (2021-2026) & ($ millions)
Table 75. Europe Injectable Sumatriptan Sales Forecast by Country (2021-2026) & (K Units)
Table 76. Europe Injectable Sumatriptan Revenue Forecast by Country (2021-2026) & ($ millions)
Table 77. Middle East & Africa Injectable Sumatriptan Sales Forecast by Country (2021-2026) & (K Units)
Table 78. Middle East & Africa Injectable Sumatriptan Revenue Forecast by Country (2021-2026) & ($ millions)
Table 79. Global Injectable Sumatriptan Sales Forecast by Type (2021-2026) & (K Units)
Table 80. Global Injectable Sumatriptan Sales Market Share Forecast by Type (2021-2026)
Table 81. Global Injectable Sumatriptan Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 82. Global Injectable Sumatriptan Revenue Market Share Forecast by Type (2021-2026)
Table 83. Global Injectable Sumatriptan Sales Forecast by Application (2021-2026) & (K Units)
Table 84. Global Injectable Sumatriptan Sales Market Share Forecast by Application (2021-2026)
Table 85. Global Injectable Sumatriptan Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 86. Global Injectable Sumatriptan Revenue Market Share Forecast by Application (2021-2026)
Table 87. GlaxoSmithKline Basic Information, Injectable Sumatriptan Manufacturing Base, Sales Area and Its Competitors
Table 88. GlaxoSmithKline Injectable Sumatriptan Product Offered
Table 89. GlaxoSmithKline Injectable Sumatriptan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 90. GlaxoSmithKline Main Business
Table 91. GlaxoSmithKline Latest Developments
Table 92. Pfizer Basic Information, Injectable Sumatriptan Manufacturing Base, Sales Area and Its Competitors
Table 93. Pfizer Injectable Sumatriptan Product Offered
Table 94. Pfizer Injectable Sumatriptan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 95. Pfizer Main Business
Table 96. Pfizer Latest Developments
Table 97. Teva Basic Information, Injectable Sumatriptan Manufacturing Base, Sales Area and Its Competitors
Table 98. Teva Injectable Sumatriptan Product Offered
Table 99. Teva Injectable Sumatriptan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 100. Teva Main Business
Table 101. Teva Latest Developments
Table 102. Sun Pharma Basic Information, Injectable Sumatriptan Manufacturing Base, Sales Area and Its Competitors
Table 103. Sun Pharma Injectable Sumatriptan Product Offered
Table 104. Sun Pharma Injectable Sumatriptan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 105. Sun Pharma Main Business
Table 106. Sun Pharma Latest Developments
List of Figures
Figure 1. Picture of Injectable Sumatriptan
Figure 2. Injectable Sumatriptan Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Injectable Sumatriptan Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Injectable Sumatriptan Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Injectable Sumatriptan Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of 4mg
Figure 10. Product Picture of 6mg
Figure 11. Product Picture of Others
Figure 12. Global Injectable Sumatriptan Sales Market Share by Type in 2020
Figure 13. Global Injectable Sumatriptan Revenue Market Share by Type (2016-2021)
Figure 14. Injectable Sumatriptan Consumed in Hospitals
Figure 15. Global Injectable Sumatriptan Market: Hospitals (2016-2021) & (K Units)
Figure 16. Injectable Sumatriptan Consumed in Clinics
Figure 17. Global Injectable Sumatriptan Market: Clinics (2016-2021) & (K Units)
Figure 18. Injectable Sumatriptan Consumed in Others
Figure 19. Global Injectable Sumatriptan Market: Others (2016-2021) & (K Units)
Figure 20. Global Injectable Sumatriptan Sales Market Share by Application (2016-2021)
Figure 21. Global Injectable Sumatriptan Revenue Market Share by Application in 2020
Figure 22. Injectable Sumatriptan Revenue Market by Company in 2020 ($ Million)
Figure 23. Global Injectable Sumatriptan Revenue Market Share by Company in 2020
Figure 24. Global Injectable Sumatriptan Sales Market Share by Regions (2016-2021)
Figure 25. Global Injectable Sumatriptan Revenue Market Share by Region in 2020
Figure 26. Americas Injectable Sumatriptan Sales 2016-2021 (K Units)
Figure 27. Americas Injectable Sumatriptan Revenue 2016-2021 ($ Millions)
Figure 28. APAC Injectable Sumatriptan Sales 2016-2021 (K Units)
Figure 29. APAC Injectable Sumatriptan Revenue 2016-2021 ($ Millions)
Figure 30. Europe Injectable Sumatriptan Sales 2016-2021 (K Units)
Figure 31. Europe Injectable Sumatriptan Revenue 2016-2021 ($ Millions)
Figure 32. Middle East & Africa Injectable Sumatriptan Sales 2016-2021 (K Units)
Figure 33. Middle East & Africa Injectable Sumatriptan Revenue 2016-2021 ($ Millions)
Figure 34. Americas Injectable Sumatriptan Sales Market Share by Country in 2020
Figure 35. Americas Injectable Sumatriptan Revenue Market Share by Country in 2020
Figure 36. Americas Injectable Sumatriptan Sales Market Share by Type in 2020
Figure 37. Americas Injectable Sumatriptan Sales Market Share by Application in 2020
Figure 38. United States Injectable Sumatriptan Revenue Growth 2016-2021 ($ Millions)
Figure 39. Canada Injectable Sumatriptan Revenue Growth 2016-2021 ($ Millions)
Figure 40. Mexico Injectable Sumatriptan Revenue Growth 2016-2021 ($ Millions)
Figure 41. Brazil Injectable Sumatriptan Revenue Growth 2016-2021 ($ Millions)
Figure 42. APAC Injectable Sumatriptan Sales Market Share by Region in 2020
Figure 43. APAC Injectable Sumatriptan Revenue Market Share by Regions in 2020
Figure 44. APAC Injectable Sumatriptan Sales Market Share by Type in 2020
Figure 45. APAC Injectable Sumatriptan Sales Market Share by Application in 2020
Figure 46. China Injectable Sumatriptan Revenue Growth 2016-2021 ($ Millions)
Figure 47. Japan Injectable Sumatriptan Revenue Growth 2016-2021 ($ Millions)
Figure 48. Korea Injectable Sumatriptan Revenue Growth 2016-2021 ($ Millions)
Figure 49. Southeast Asia Injectable Sumatriptan Revenue Growth 2016-2021 ($ Millions)
Figure 50. India Injectable Sumatriptan Revenue Growth 2016-2021 ($ Millions)
Figure 51. Australia Injectable Sumatriptan Revenue Growth 2016-2021 ($ Millions)
Figure 52. Europe Injectable Sumatriptan Sales Market Share by Country in 2020
Figure 53. Europe Injectable Sumatriptan Revenue Market Share by Country in 2020
Figure 54. Europe Injectable Sumatriptan Sales Market Share by Type in 2020
Figure 55. Europe Injectable Sumatriptan Sales Market Share by Application in 2020
Figure 56. Germany Injectable Sumatriptan Revenue Growth 2016-2021 ($ Millions)
Figure 57. France Injectable Sumatriptan Revenue Growth 2016-2021 ($ Millions)
Figure 58. UK Injectable Sumatriptan Revenue Growth 2016-2021 ($ Millions)
Figure 59. Italy Injectable Sumatriptan Revenue Growth 2016-2021 ($ Millions)
Figure 60. Russia Injectable Sumatriptan Revenue Growth 2016-2021 ($ Millions)
Figure 61. Middle East & Africa Injectable Sumatriptan Sales Market Share by Country in 2020
Figure 62. Middle East & Africa Injectable Sumatriptan Revenue Market Share by Country in 2020
Figure 63. Middle East & Africa Injectable Sumatriptan Sales Market Share by Type in 2020
Figure 64. Middle East & Africa Injectable Sumatriptan Sales Market Share by Application in 2020
Figure 65. Egypt Injectable Sumatriptan Revenue Growth 2016-2021 ($ Millions)
Figure 66. South Africa Injectable Sumatriptan Revenue Growth 2016-2021 ($ Millions)
Figure 67. Israel Injectable Sumatriptan Revenue Growth 2016-2021 ($ Millions)
Figure 68. Turkey Injectable Sumatriptan Revenue Growth 2016-2021 ($ Millions)
Figure 69. GCC Country Injectable Sumatriptan Revenue Growth 2016-2021 ($ Millions)
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles